Efficacy and safety of empagliflozin twice daily versus once daily in patients with type 2 diabetes inadequately controlled on metformin: a 16‐week, randomized, placebo‐controlled trial

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 699-702

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial*

By Cantor† Louis B.   Safyan Eleonora   Liu Ching-Chi   Batoosingh Amy L.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2035-2043

Informa Healthcare

Access to resources Recommend Favorite

Alternate-day versus once-daily administration of amphotericin B in the treatment of cryptococcal meningitis: A randomized controlled trial

By Techapornroong Malee   Suankratay Chusana  

Scandinavian Journal of Infectious Diseases, Vol. 39, Iss. 10, 2007-12 ,pp. : 896-901

Informa Healthcare

Access to resources Recommend Favorite

Optimum Dose of Once‐Daily Oxybutynin Patch in Japanese Patients with Overactive Bladder: A Randomized Double‐Blind Trial Versus Placebo

By  

LUTS, Vol. 8, Iss. 3, 2016-09 ,pp. : 150-158

John Wiley & Sons Inc

Access to resources Recommend Favorite

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis

By Klausner Howard A.   Brown Patricia   Peterson Janet   Kaul Simrati   Khashab Mohammed   Fisher Alan C.   Kahn James B.  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2637-2645

Informa Healthcare

Access to resources Recommend Favorite